News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2022 Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing Shelley Wood December 07, 2022
News Conference News PCR London Valves 2022 TAVI Dipped Worldwide in Early COVID-19 Waves, but That’s Not the Whole Story Shelley Wood November 30, 2022
News Conference News PCR London Valves 2022 Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains Shelley Wood November 28, 2022
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Conference News PCR London Valves 2021 ‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI Michael O'Riordan November 25, 2021
News Conference News PCR London Valves 2021 Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry Shelley Wood November 24, 2021
News Conference News PCR London Valves 2020 No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION Shelley Wood November 26, 2020
News Conference News PCR London Valves 2020 CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures Shelley Wood November 24, 2020